Search on this blog

Search on this blog

Register Now

๐ŸŒ Global Participation

The 2025 conference witnessed participation from 40+ countries, representing top universities, hospitals, research institutes, and medical organizations. With a strong international presence, the event fostered rich cross-cultural dialogue and multi-disciplinary collaboration.

Past Conference Report- 2025

3rd European Congress of Neurology and Neuropsychiatry –
Conference Report February 17-18, 2025, Amsterdam, Netherlands

Day 1 Highlights โ€“ February 17, 2025
Venue: Park Plaza Amsterdam Airport, Amsterdam, Netherlands
Theme: Brain and Mental Health: Exploring the Intersection of Neurology and Psychiatry
Website: www.neurologyconf.com

The 3rd European Congress of Neurology and Neuropsychiatry (Neuro 2025), held in the scenic city of Amsterdam, Netherlands, emerged as a monumental event in the field of neuroscience. Organized by CLS Event and Publication Pvt. Ltd., this international congress convened a distinguished array of neurologists, neuropsychiatrists, neurosurgeons, neuroscientists, and allied healthcare professionals, all converging under a unifying theme: โ€œBrain and Mental Health: Exploring the Intersection of Neurology and Psychiatry.โ€

This two-day scientific extravaganza served as a fertile platform for cross-disciplinary exchange, innovation, and collaborationโ€”reflecting the evolving interplay between neurology and mental health. The event upheld its commitment to academic excellence, innovation, and global outreach, attracting participants from over 30 countries.

Opening Ceremony & Keynotes

The congress commenced with a warm welcome and opening remarks by Prof. Dr. Allal Boutajangout from the New York University School of Medicine, USA. His insightful presidential address set the tone for the conference, emphasizing the critical need for integrated approaches in understanding neurological and psychiatric comorbidities.

The keynote presentations were equally riveting, beginning with Dr. Stephen E. Nadeau (University of Florida, USA), who delivered two sequential talks on Neural Population Computing and Emotional and Neuropsychiatric Disorders in Alzheimerโ€™s Disease. His work underscored the complexity of cognitive processes and their disruption in degenerative diseases. Following this, Prof. Dr. Allal Boutajangout discussed Plasma Biomarkers in Alzheimerโ€™s Disease, highlighting cutting-edge research in differential diagnosis across racial demographics. Morning Scientific Sessions After a brief networking tea session, Dr. Marit Ruitenberg (Leiden University, Netherlands) presented on Cognition and Movement in Neurodegenerative Disorders, followed by Dr. Kamlesh Jha (AIIMS, India), who showcased novel diagnostic tools like fNIRS and qEEG for pediatric seizure disorders. Dr. Aparna Wagle Shukla (University of Florida, USA) concluded the pre-lunch session with her impactful lecture on Neuromodulation for Movement Disorders, exploring non-invasive and deep brain stimulation approaches. Session I โ€“ Neuropsychology & Parkinsonโ€™s Disease Chaired by Dr. Stephen Nadeau and Dr. Anand Pratap Singh, the post-lunch session focused on neuropsychological research and Parkinsonโ€™s disease. Highlights included:
  • Mobeena Ghuman (NYU Grossman School of Medicine, USA) presenting promising results from Affibody applications in aged animal models of Alzheimerโ€™s.
  • Dr. Dipesh Sonawane (Sun Pharma, India) offered a detailed post-hoc analysis of Pimavanserin in Parkinsonโ€™s psychosis.
  • Dr. Ashutosh M. Shukla (University of Florida, USA) explored the phenotypic link between Parkinsonโ€™s and end-stage kidney disease.
  • Dr. Francisco J.L. Caballero (University of Pittsburgh, USA) examined midbrain auditory processing deficits in early psychosis.
Additional sessions included presentations on acquired brain injury, insomnia, and transcranial photobiomodulation in Alzheimerโ€™s patients. The day concluded with presentations by:
  • Dr. K. Tugberk Ozdemir (Turkey) on deep brain stimulation.
  • Asli Beyza GUL (UK) on digital Parkinsonโ€™s care.
  • Viลกnja Bandalo (Croatia) on creative arts therapy for neurological rehabilitation.
Awards Ceremony โ€“ Day 1 The Young Researcher Award and Travel Award sessions recognized emerging voices in neuroscience and celebrated early-career innovation.
Keynote Speakers:
  • Dr. Allal Boutajangout, affiliated with NYU Langone Health in the United States.
  • Dr. Stephen E Nadeau, hailing from the University of Florida, USA
  • Dr. Marit Ruitenberg, Leiden University, Netherlands
  • Dr. Gary L. Pattee, associated with Bryan Medical Center in the USA
  • Dr. Anand Pratap Singh, representing Gautam Buddha University in India
  • Dr. Giuseppe Bonavina, Montecatone Rehabilitation Institute, Italy[Additional 6 Keynote Speakers]
Closing Ceremony and Awards The congress culminated with the Awards & CME Certification Ceremony, recognizing exemplary contributions across categories: Fellowship Awards
  • Prof. Dr. Allal Boutajangout (USA)
  • Dr. Anand Pratap Singh (India)
  • Dr. Giuseppe Bonavina (Italy)
Student Travel Awards
  • Mobeena Ghuman (USA)
  • Emna Benmansour (Tunisia)
Poster Awards
  • Dr. Dipesh Sonawane (India)
  • Lusi Khairunnisa (Indonesia)
  • Ashleigh Patterson (USA)
Best Research Awards
  • Dr. Aparna Wagle Shukla (USA)
  • Miss Hanin Salem (UK โ€“ Virtual)
  • Dr. Hebatalla Saher Hashem (Egypt โ€“ Virtual)
Each awardee was celebrated for advancing the global understanding of neurological science through their dedicated research and clinical efforts.
Day 2 Highlights โ€“ February 18, 2025 Keynote Presentations Day 2 commenced with a trio of powerful keynotes:
  • Dr. Giuseppe Bonavina (Italy) discussed HRQoL in chronic migraine from both clinical and anthropological perspectives.
  • Dr. Anand Pratap Singh (India) spoke on P300 wave potentials and their diagnostic relevance in neuropsychiatric disorders.
  • Dr. Adam Broncel (Poland) presented his research on auricular vagal nerve stimulation for mild cognitive impairment.
Later, Dr. Stephen Nadeau returned to deliver a compelling lecture on The Basal Ganglia, while Prof. Ljudmila Stojanovich (Serbia) explored the multidisciplinary management of neurovascular failures linked to antiphospholipid antibodies. Session II โ€“ Neurological Advances This session examined cutting-edge findings in neurodegeneration and epilepsy:
  • Fatima Al-Bakri (UK) analyzed APOE polymorphisms in ischemic stroke.
  • Prof. Gehan A-R Ahmed (Egypt) presented on beta-amyloid aggregation and clearance using FTIR spectroscopy.
  • Dr. Shaw Keith Lau (UK) discussed carotid dissection cases manifesting as sudden-onset dysphagia.
  • Dr. Gayatri Kumar (India) demonstrated emotion detection in schizophrenia using affective computing.
  • John F. Decarlo (USA) and Emna Benmansour (Tunisia) presented research on epigenetic effects and neurobehavioral toxicity in neuropsychiatric contexts.
Poster and Virtual Presentations The afternoon was dedicated to Poster Presentations (PP01โ€“PP14) and Virtual Presentations (VT01โ€“VT08), showcasing global talent and innovative research across a range of neurological and neuropsychiatric disciplines. Key poster topics included:
  • AI in migraine management.
  • EEG analysis for anxiety and eating disorders.
  • Stroke risk in inflammatory bowel disease.
  • Neurological side effects of medications.
  • Post-COVID neuropsychiatric manifestations.
  • Gender-based olfactory receptor studies in hypertension.
Virtual presenters explored epilepsy, autism, schizophrenia, and neurodevelopmental psychology, adding diverse, cross-continental insights to the program. Conclusion Neuro 2025 succeeded in its mission to bridge neurology and psychiatry through robust academic exchange, cross-border collaborations, and groundbreaking research dissemination. The congress was marked by scientific depth, clinical relevance, and a welcoming, intellectually vibrant environment. Participants left inspired, with renewed vigor to push the boundaries of neuroscience, and eagerly await the 4th European Congress โ€“ Neuro 2026, scheduled to be held in the historic city of Paris, France.

Past Conference Report- 2024

2nd European Congress of Neurology and Neuropsychiatry – Conference Report
February 19-20, 2024, London, UK

Day 1: February 19, 2024

The 2nd European Congress of Neurology and Neuropsychiatry commenced with enthusiasm and scholarly discussions at the heart of London, UK. The event brought together renowned neurologists, neuropsychiatrists, and researchers from diverse corners of the world.

The conference kicked off at 09:30 with a warm welcome by Dr. Allal Boutajangout from NYU Langone Health, USA. His opening remarks set the tone for the scientific feast that followed. The first keynote presentation, “Neural Population Computing Part 1,” unfolded the basic principles of population dynamics and cognitive function, presented by Dr. Stephen E. Nadeau from the University of Florida, USA.

The morning continued with an intriguing exploration of plasma biomarkers in Alzheimerโ€™s disease and COVID-19 subjects, eloquently discussed by Dr. Allal Boutajangout. The networking session before lunch provided an excellent opportunity for attendees to connect and share insights.

Post-lunch, Prof. Anand Pratap Singh from Gautam Buddha University, India, captivated the audience with his talk on “Exploring Psychopathology with Brain Fingerprinting Technique (BFT): A Paradigm Shift in Psychiatry.” The session continued with Dr. Gary Pattee from the University of Nebraska Medical Center, USA, delving into the intriguing question, “Is ALS Onset Accelerated by Chloroviruses and Delayed by Antiviral Immune Responses?”

The afternoon session unfolded diverse topics in the realm of neurology and neuropsychiatry, covering a rare case of pituitary dysfunction with Moyamoya disease, investigating molecular markers in treatment-resistant depression, and exploring the effectiveness of computer-assisted cognitive retraining among patients with mild cognitive impairment.

The day concluded with a series of impactful poster presentations, highlighting research on cognitive flexibility in experimental animals, depression and neuroplasticity, and unique case reports like late-onset Guillain Barrรฉ syndrome post-SARS-CoV-2 infection and acute psychosis with isotretinoin initiation.

The Q/A session provided a platform for engaging discussions, and the day culminated in an award ceremony, recognizing the contributions of speakers, delegates, and researchers.

Past Conference Report- 2023

European Congress of Neurology and Neuropsychiatry – Conference Report March 6-7, 2023 – Canada The European Congress of Neurology and Neuropsychiatry 2023 held on March 6th and 7th in Canada was a resounding success, bringing together a diverse and engaged audience of over 100 attendees, both physically and online. The event showcased the latest advancements and breakthroughs in the fields of neurology and neuropsychiatry and featured a remarkable lineup of speakers, mentors, and poster presentations. In conclusion, the European Congress of Neurology and Neuropsychiatry 2023 was a remarkable event that united experts, researchers, clinicians, and students from around the world. The engaging keynote speakers, diverse neurology sessions, insightful poster presentations, and successful mentorship program made this conference a pivotal platform for advancing the fields of neurology and neuropsychiatry. Members from Top association attends Neurology 2023:
  1. American Academy of Neurology (AAN)
  2. European Academy of Neurology (EAN)
  3. World Federation of Neurology (WFN)
  4. American Neurological Association (ANA)
  5. International Parkinson and Movement Disorder Society (MDS)
  6. European Federation of Neurological Societies (EFNS)
  7. Child Neurology Society (CNS)
  8. Neurocritical Care Society (NCS)
  9. Society for Neuroscience (SFN)
  10. American Epilepsy Society (AES)
  11. European Society of Neurosonology and Cerebral Hemodynamics (ESNCH)
  12. Asian-Oceanian Association of Neurology (AOAN)
  13. Canadian Neurological Sciences Federation (CNSF)
  14. Neurology Section of the Royal Society of Medicine (RSM)
  15. Movement Disorders Society (MDS)
  16. Peripheral Nerve Society (PNS)
  17. Society for Neuro-Oncology (SNO)
  18. European Stroke Organisation (ESO)
  19. American Headache Society (AHS)
  20. Neurology India Society
General Queries Registration Queries